LUCIRA HEALTH INC (LHDX) Forecast, Price Target & Analyst Ratings

NASDAQ:LHDX • US54948U1051

Current stock price

0.4523 USD
-0.11 (-19.23%)
At close:
0.405 USD
-0.05 (-10.46%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LUCIRA HEALTH INC (LHDX).

Forecast Snapshot

Consensus Price Target

Price Target
$0.77
+ 69.14% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 10, 2023
Period
Q4 / 2022
EPS Estimate
-$0.41
Revenue Estimate
35.353M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$0.77
Upside
+ 69.14%
From current price of $0.45 to mean target of $0.77, Based on 6 analyst forecasts
Low
$0.76
Median
$0.77
High
$0.79

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for LHDX. The average price target is 0.77 USD. This implies a price increase of 69.14% is expected in the next year compared to the current price of 0.4523.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LHDX Current Analyst RatingLHDX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

LHDX Historical Analyst RatingsLHDX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
LHDX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about LHDX.
In the previous month the buy percentage consensus was at a similar level.
LHDX was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-05-04William BlairDowngrade Outperform -> Market Perform
2021-04-13B of A SecuritiesDowngrade Buy -> Underperform
2021-03-02William BlairInitiate Outperform
2021-03-02B of A SecuritiesInitiate Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 10, 2023
Period
Q4 / 2022
EPS Estimate
-$0.41
Revenue Estimate
35.353M
Revenue Q2Q
-42.16%
EPS Q2Q
-4,180.00%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-52.09%
EPS (1 Month)
0.00%
EPS (3 Months)
-280.95%

Next Earnings Summary

LHDX is expected to report earnings on 5/10/2023. The consensus EPS estimate for the next earnings is -0.41 USD and the consensus revenue estimate is 35.35M USD.
The next earnings revenue estimate has been revised downward by 52.09% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023
Revenue
YoY % growth
LHDX revenue by date.LHDX revenue by date.
270K93.055M
34,364.81%		226.7M
143.62%		127.5M
-43.76%
EBITDA
YoY % growth
LHDX ebitda by date.LHDX ebitda by date.
-13.58M
-41.90%		-31.65M
-133.06%		-53.527M
-69.12%		-149.532M
-179.36%		-26.653M
82.18%
EBIT
YoY % growth
LHDX ebit by date.LHDX ebit by date.
-13.86M
-41.14%		-31.93M
-130.38%		-57.198M
-79.14%		-155.285M
-171.49%		-31.875M
79.47%
Operating Margin
LHDX operating margin by date.LHDX operating margin by date.
N/A-11,825.93%-61.47%-68.50%-25.00%
EPS
YoY % growth
LHDX eps by date.LHDX eps by date.
N/AN/A-1.38-0.23
83.00%		-0.59
-152.17%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 22
EPS
Q2Q % growth		-0.41
-4,180.00%
Revenue
Q2Q % growth		35.353M
-42.16%
EBITDA
Q2Q % growth		-18.105M
-2,758.59%
EBIT
Q2Q % growth		-18.737M
-526.67%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LHDX Yearly Revenue VS EstimatesLHDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 50M 100M 150M 200M
LHDX Yearly EPS VS EstimatesLHDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 -0.5 -1 -1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

LUCIRA HEALTH INC / LHDX Forecast FAQ

What do analysts expect the price target to be for LUCIRA HEALTH INC (LHDX)?

6 analysts have analysed LHDX and the average price target is 0.77 USD. This implies a price increase of 69.14% is expected in the next year compared to the current price of 0.4523.

What is the next earnings date for LHDX stock?

LUCIRA HEALTH INC (LHDX) will report earnings on 2023-05-10.

What are the consensus estimates for LUCIRA HEALTH INC (LHDX) next earnings?

The consensus EPS estimate for the next earnings of LUCIRA HEALTH INC (LHDX) is -0.41 USD and the consensus revenue estimate is 35.35M USD.

How do analysts rate LUCIRA HEALTH INC (LHDX)?

The consensus rating for LUCIRA HEALTH INC (LHDX) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.